Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
-4.35%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$70.7B
AUM Growth
-$13.8B
Cap. Flow
-$9.12B
Cap. Flow %
-12.91%
Top 10 Hldgs %
10.57%
Holding
4,619
New
443
Increased
1,322
Reduced
2,173
Closed
639

Sector Composition

1 Healthcare 19.38%
2 Technology 18.55%
3 Consumer Staples 10.17%
4 Consumer Discretionary 9.68%
5 Financials 8.23%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TDIV icon
3351
First Trust NASDAQ Technology Dividend Index Fund
TDIV
$3.68B
$219K ﹤0.01%
5,000
-3,500
-41% -$153K
ASLN
3352
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$219K ﹤0.01%
9,145
-2,752
-23% -$65.9K
AUBN icon
3353
Auburn National Bancorp
AUBN
$89.1M
$217K ﹤0.01%
9,441
+200
+2% +$4.6K
GOCO icon
3354
GoHealth
GOCO
$77.7M
$214K ﹤0.01%
40,224
-80,203
-67% -$427K
ZOM
3355
DELISTED
Zomedica Corp.
ZOM
$214K ﹤0.01%
1,015,500
-1,492,000
-60% -$314K
BLPH
3356
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$214K ﹤0.01%
196,191
-13,208
-6% -$14.4K
MGC icon
3357
Vanguard Mega Cap 300 Index ETF
MGC
$7.84B
$212K ﹤0.01%
+1,700
New +$212K
ML
3358
DELISTED
MoneyLion Inc.
ML
$212K ﹤0.01%
7,920
+3,290
+71% +$88.1K
SIF icon
3359
SIFCO Industries
SIF
$44.8M
$211K ﹤0.01%
68,634
-20,500
-23% -$63K
FSBC icon
3360
Five Star Bancorp
FSBC
$703M
$210K ﹤0.01%
7,400
-400
-5% -$11.4K
NMRK icon
3361
Newmark Group
NMRK
$3.4B
$210K ﹤0.01%
26,000
-9,700
-27% -$78.3K
OCG icon
3362
Oriental Culture Holding
OCG
$84.2M
$209K ﹤0.01%
49,220
+22,120
+82% +$93.9K
CVT
3363
DELISTED
Cvent Holding Corp. Common Stock
CVT
$209K ﹤0.01%
39,800
-4,700
-11% -$24.7K
APVO icon
3364
Aptevo Therapeutics
APVO
$4.93M
$208K ﹤0.01%
2
CARV icon
3365
Carver Bancorp
CARV
$11.2M
$208K ﹤0.01%
51,887
-4,030
-7% -$16.2K
CCM
3366
Concord Medical Services
CCM
$24.8M
$208K ﹤0.01%
11,260
-1,690
-13% -$31.2K
FXL icon
3367
First Trust Technology AlphaDEX Fund
FXL
$1.42B
$208K ﹤0.01%
2,400
-2,500
-51% -$217K
IMBI
3368
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$208K ﹤0.01%
325,348
-24,600
-7% -$15.7K
ABEO icon
3369
Abeona Therapeutics
ABEO
$346M
$207K ﹤0.01%
68,137
-27,790
-29% -$84.4K
VYNE icon
3370
VYNE Therapeutics
VYNE
$8.04M
$207K ﹤0.01%
51,611
-585
-1% -$2.35K
EXTN
3371
DELISTED
Exterran Corporation
EXTN
$207K ﹤0.01%
49,800
-28,300
-36% -$118K
SEEL
3372
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$206K ﹤0.01%
52
-249
-83% -$986K
HWBK icon
3373
Hawthorn Bancshares
HWBK
$225M
$205K ﹤0.01%
9,730
-4,992
-34% -$105K
NEXT icon
3374
NextDecade
NEXT
$2.01B
$205K ﹤0.01%
+34,073
New +$205K
SILC icon
3375
Silicom
SILC
$104M
$205K ﹤0.01%
5,800
-500
-8% -$17.7K